OTCMKTS:CERPQ

Cereplast Competitors

$0.39
-0.16 (-29.09 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.33
$0.57
50-Day Range
$0.09
$0.95
52-Week Range
$0.01
$0.70
Volume1.02 million shs
Average Volume489,570 shs
Market Capitalization$29.11 million
P/E RatioN/A
Dividend YieldN/A
Beta3.04

Cereplast (OTCMKTS:CERPQ) Vs. DOW, DD, ALB, EMN, HXL, and AVNT

Should you be buying CERPQ stock or one of its competitors? Companies in the industry of "plastics materials & resins" are considered alternatives and competitors to Cereplast, including DOW (DOW), DuPont de Nemours (DD), Albemarle (ALB), Eastman Chemical (EMN), Hexcel (HXL), and Avient (AVNT).

DOW (NYSE:DOW) and Cereplast (OTCMKTS:CERPQ) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk.

Institutional and Insider Ownership

67.0% of DOW shares are held by institutional investors. 0.4% of DOW shares are held by insiders. Comparatively, 1.1% of Cereplast shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

DOW has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500. Comparatively, Cereplast has a beta of 3.04, suggesting that its share price is 204% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for DOW and Cereplast, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
DOW113602.25
Cereplast0000N/A

DOW currently has a consensus target price of $57.4211, indicating a potential downside of 9.01%. Given DOW's higher possible upside, equities analysts clearly believe DOW is more favorable than Cereplast.

Profitability

This table compares DOW and Cereplast's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
DOW4.86%13.57%3.02%
CereplastN/AN/AN/A

Valuation and Earnings

This table compares DOW and Cereplast's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DOW$38.54 billion1.22$1.23 billion$1.6638.02
CereplastN/AN/AN/AN/AN/A

DOW has higher revenue and earnings than Cereplast.

Summary

DOW beats Cereplast on 7 of the 9 factors compared between the two stocks.

DuPont de Nemours (NYSE:DD) and Cereplast (OTCMKTS:CERPQ) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Earnings & Valuation

This table compares DuPont de Nemours and Cereplast's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DuPont de Nemours$20.40 billion2.02$-2,951,000,000.00$3.3623.01
CereplastN/AN/AN/AN/AN/A

Cereplast has lower revenue, but higher earnings than DuPont de Nemours.

Profitability

This table compares DuPont de Nemours and Cereplast's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
DuPont de Nemours15.97%6.76%3.74%
CereplastN/AN/AN/A

Insider and Institutional Ownership

70.5% of DuPont de Nemours shares are held by institutional investors. 0.2% of DuPont de Nemours shares are held by company insiders. Comparatively, 1.1% of Cereplast shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

DuPont de Nemours has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, Cereplast has a beta of 3.04, suggesting that its share price is 204% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for DuPont de Nemours and Cereplast, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
DuPont de Nemours012702.37
Cereplast0000N/A

DuPont de Nemours presently has a consensus target price of $82.7059, indicating a potential upside of 6.97%. Given DuPont de Nemours' higher possible upside, research analysts clearly believe DuPont de Nemours is more favorable than Cereplast.

Summary

DuPont de Nemours beats Cereplast on 7 of the 9 factors compared between the two stocks.

Cereplast (OTCMKTS:CERPQ) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Cereplast and Albemarle, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cereplast0000N/A
Albemarle371002.35

Albemarle has a consensus target price of $142.1429, suggesting a potential downside of 11.94%. Given Albemarle's higher possible upside, analysts plainly believe Albemarle is more favorable than Cereplast.

Earnings and Valuation

This table compares Cereplast and Albemarle's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CereplastN/AN/AN/AN/AN/A
Albemarle$3.13 billion6.02$375.76 million$4.1239.18

Albemarle has higher revenue and earnings than Cereplast.

Risk & Volatility

Cereplast has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500.

Profitability

This table compares Cereplast and Albemarle's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CereplastN/AN/AN/A
Albemarle11.31%9.66%4.45%

Insider & Institutional Ownership

81.0% of Albemarle shares are owned by institutional investors. 1.1% of Cereplast shares are owned by company insiders. Comparatively, 0.6% of Albemarle shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Albemarle beats Cereplast on 7 of the 9 factors compared between the two stocks.

Eastman Chemical (NYSE:EMN) and Cereplast (OTCMKTS:CERPQ) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Insider and Institutional Ownership

84.2% of Eastman Chemical shares are held by institutional investors. 1.9% of Eastman Chemical shares are held by company insiders. Comparatively, 1.1% of Cereplast shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and target prices for Eastman Chemical and Cereplast, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eastman Chemical03802.73
Cereplast0000N/A

Eastman Chemical currently has a consensus target price of $116.75, suggesting a potential downside of 1.92%. Given Eastman Chemical's higher possible upside, analysts plainly believe Eastman Chemical is more favorable than Cereplast.

Earnings & Valuation

This table compares Eastman Chemical and Cereplast's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eastman Chemical$8.47 billion1.92$478 million$6.1519.36
CereplastN/AN/AN/AN/AN/A

Eastman Chemical has higher revenue and earnings than Cereplast.

Risk & Volatility

Eastman Chemical has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, Cereplast has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500.

Profitability

This table compares Eastman Chemical and Cereplast's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eastman Chemical5.72%13.86%5.32%
CereplastN/AN/AN/A

Summary

Eastman Chemical beats Cereplast on 8 of the 9 factors compared between the two stocks.

Hexcel (NYSE:HXL) and Cereplast (OTCMKTS:CERPQ) are both aerospace companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends.

Earnings and Valuation

This table compares Hexcel and Cereplast's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hexcel$1.50 billion3.48$31.70 million$0.25249.32
CereplastN/AN/AN/AN/AN/A

Hexcel has higher revenue and earnings than Cereplast.

Volatility & Risk

Hexcel has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500. Comparatively, Cereplast has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Hexcel and Cereplast, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hexcel57201.79
Cereplast0000N/A

Hexcel currently has a consensus target price of $46.2667, indicating a potential downside of 25.77%. Given Hexcel's higher probable upside, equities research analysts clearly believe Hexcel is more favorable than Cereplast.

Profitability

This table compares Hexcel and Cereplast's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hexcel-1.94%-2.80%-1.38%
CereplastN/AN/AN/A

Insider & Institutional Ownership

98.2% of Hexcel shares are held by institutional investors. 1.4% of Hexcel shares are held by company insiders. Comparatively, 1.1% of Cereplast shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Hexcel beats Cereplast on 5 of the 9 factors compared between the two stocks.

Cereplast (OTCMKTS:CERPQ) and Avient (NYSE:AVNT) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, analyst recommendations, profitability, dividends, institutional ownership and risk.

Earnings and Valuation

This table compares Cereplast and Avient's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CereplastN/AN/AN/AN/AN/A
Avient$3.24 billion1.37$131.60 million$1.7328.23

Avient has higher revenue and earnings than Cereplast.

Risk & Volatility

Cereplast has a beta of 3.04, indicating that its share price is 204% more volatile than the S&P 500. Comparatively, Avient has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings for Cereplast and Avient, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cereplast0000N/A
Avient02802.80

Avient has a consensus price target of $50.10, indicating a potential upside of 2.60%. Given Avient's higher probable upside, analysts plainly believe Avient is more favorable than Cereplast.

Profitability

This table compares Cereplast and Avient's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CereplastN/AN/AN/A
Avient4.82%11.95%4.19%

Insider and Institutional Ownership

93.3% of Avient shares are owned by institutional investors. 1.1% of Cereplast shares are owned by insiders. Comparatively, 1.5% of Avient shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Avient beats Cereplast on 8 of the 9 factors compared between the two stocks.

pixel
Ad Resource Stock Digest
$1.7 Trillion Clean Energy Mandate to Deliver Stock Gains in 2021
Newly-minted stock market millionaires will be making a tour de force in 2021 by being early on select green energy stocks. This US$0.25 stock just seized control of an ultra-rare clean energy metal America needs to lead the green energy revolution.

Cereplast Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DOW logo
DOW
DOW
2.1$63.11-1.8%$47.14 billion$38.54 billion24.09News Coverage
DuPont de Nemours logo
DD
DuPont de Nemours
2.2$77.32-1.2%$41.15 billion$20.40 billion13.52Dividend Announcement
Albemarle logo
ALB
Albemarle
2.4$161.41-2.1%$18.84 billion$3.13 billion48.18
Eastman Chemical logo
EMN
Eastman Chemical
2.3$119.04-4.1%$16.23 billion$8.47 billion33.07Analyst Upgrade
News Coverage
Gap Up
Hexcel logo
HXL
Hexcel
1.6$62.33-2.7%$5.22 billion$1.50 billion-214.93Analyst Revision
Avient logo
AVNT
Avient
2.2$48.83-3.3%$4.46 billion$3.24 billion25.17
Rogers logo
ROG
Rogers
1.8$190.93-0.3%$3.57 billion$802.58 million52.74
PCT
PureCycle Technologies
2.0$22.67-1.2%$2.66 billionN/A0.00
Sinopec Shanghai Petrochemical logo
SHI
Sinopec Shanghai Petrochemical
1.4$23.47-3.9%$2.53 billion$10.83 billion5.60Gap Down
Trinseo logo
TSE
Trinseo
1.7$58.47-3.8%$2.27 billion$3.04 billion20.09Dividend Announcement
DNMR
Danimer Scientific
1.8$23.23-2.2%$1.99 billion$47.33 million-54.02
Kraton logo
KRA
Kraton
1.9$33.07-5.5%$1.06 billion$1.56 billion-2.63Gap Up
AdvanSix logo
ASIX
AdvanSix
1.5$29.71-7.6%$833.40 million$1.16 billion12.86Gap Up
ForceField Energy logo
FNRG
ForceField Energy
0.5$0.00-0.0%$2,000.00N/A0.00
This page was last updated on 6/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.